Skip Navigation


BJA Advance Access originally published online on January 22, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/3/419    most recent
aeh062v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fuchs-Buder, T.
Right arrow Articles by Kleinschmidt, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuchs-Buder, T.
Right arrow Articles by Kleinschmidt, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2004, Vol. 92, No. 3 419-421
© 2004 The Board of Management and Trustees of the British Journal of Anaesthesia


Short Communications

Concentration of rocuronium in cerebrospinal fluid of patients undergoing cerebral aneurysm clipping{dagger}

T. Fuchs-Buder*,1, M. Strowitzki2, K. Rentsch3, J. U. Schreiber1, S. Philipp-Osterman1 and S. Kleinschmidt1

1 Department of Anaesthesia and Critical Care and 2 Department of Neurosurgery, University of Saarland, Homburg/Saar, Germany. 3 Institute for Clinical Chemistry University Hospital of Zurich, Switzerland

*Corresponding author: Département d’Anesthésie et de Réanimation, Centre Hospitalier Universitaire Nancy/Brabois, 4 Rue du Morvan, F-54500 Vandoeuvres-Les-Nancy, France. E-mail: t.fuchs-buder@chu-nancy.fr
{dagger}Declaration of interest: This study was supported in part by a grant from Organon, The Netherlands.

Background. This study assessed the concentration of rocuronium in the cerebrospinal fluid (CSF) of patients undergoing cerebral aneurysm clipping, and investigated whether the mode of administration (single bolus vs continuous infusion) influenced the CSF concentration.

Methods. Twenty patients with subarachnoid haemorrhage were randomly allocated to receive a bolus dose (bolus group), or a bolus followed by a continuous infusion of rocuronium (infusion group) (n=10 for each group). Arterial blood and ventricular CSF were sampled 2 h after the rocuronium bolus. Samples were analysed by liquid chromatography electrospray ionization-tandem mass spectrometry.

Results. Rocuronium could be detected in all the CSF samples. The mean (range) CSF concentration was 2.2 (0.9–4.6) ng ml–1 in the bolus group and 12.4 (2.4–34.6) ng ml–1 in the infusion group; P<0.01.

Conclusions. This study demonstrated that rocuronium, normally not considered to cross the blood–brain barrier, is regularly found in the CSF of patients undergoing cerebral clipping; continuous infusion of the drug led to higher plasma and CSF concentrations than after a single bolus dose.

Br J Anaesth 2004; 92: 419–21


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
S. Ezzine and F. Varin
Interstitial muscle concentrations of rocuronium under steady-state conditions in anaesthetized dogs: actual versus predicted values
Br. J. Anaesth., January 1, 2005; 94(1): 49 - 56.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.